Navigation Links
Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship
Date:12/2/2008

ased capability and adaptability Sage Intergy offers, ACC will be able to:

-- Capture the data necessary to collect the 2 percent bonus that the Centers for Medicare & Medicaid Services will begin paying in 2009 to physicians who successfully e-prescribe under Medicare Part D.

-- Send friendly, customized letters to encourage patients who are uninsured or have high-deductible health plans to work out a payment plan, rather than just receiving monthly statements followed by calls from debt collectors. This allows ACC to work in a cooperative manner with patients to implement a mutually beneficial payment schedule, which will greatly enhance patient satisfaction and retention as well as improving collections.

-- Provide innovative patient- and caregiver-friendly encounter summaries to ensure that when patients leave the office they will have information about their treatment plan at their fingertips. Cardiology care is complex and many patients, especially the elderly, often are unable to remember or relay physicians' instructions to their caregiver when they get home. The encounter summary will help enhance quality of care and timely patient adherence with the prescribed course of treatment, thus improving outcomes. Additionally, it also will provide interested patients with key information to create and maintain an online personal health record, and boost practice efficiency by reducing the volume of calls from patients and their caregivers.

-- Facilitate patient recruitment for clinical trials being performed by ACC. By embedding the criteria for all its clinical trials into the EHR alert function, ACC will be able to identify candidates for clinical trials as soon as they present before a medical assistant, nurse or physician. This will dramatically improve the efficiency of the patient identification and recruitment process.

Said Sharon Howard, senior vice preside
'/>"/>

SOURCE Sage Software Healthcare, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
2. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
3. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
4. Aerospace engineer earns Oak Ridge Associated Universities Ralph Powe Junior Faculty Award
5. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
6. 3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
7. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
10. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
11. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... ... CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product that targets fat cells for ... that are able to enter fat cells, inhibiting the formation of new fat. ...
(Date:7/28/2015)... A n ew UK company ... commercialising innovative medicines to transform patient quality of life and ... team; blue chip investor ... Ltd ("Mereo"), a recently-formed speciality biopharmaceutical company, announces that it ... blue chip institutional investors and simultaneously acquired a portfolio of ...
(Date:7/28/2015)... , July 28, 2015 Seahorse ... cell metabolism, is the provider of XF Technology ... all disease research areas. As the links between ... into cell metabolism is escalating rapidly.   ... by the Nature Publishing Group (NPG) featuring XF ...
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... the Deerfield Healthcare Innovations Fund, L.P., which will invest ... therapeutic interventions in genetic diseases, cancer, and orphan diseases. ... that can transform how therapeutics are developed and improve ... The fund, one of the largest healthcare-focused venture funds ...
Breaking Biology Technology:Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... LOS ANGELES, Oct. 13 Vista Partners announced ... Bio Medica Corporation,(Nasdaq: ABMC ) and maintains ... Director of Research at Vista Partners stated, "Sales,internationally ... lab,alliance, which give ABMC,s products exposure in numerous ...
... Houston-based Proximity Systems ... WorkStations: one year ... installing 400,Proximity Systems Computer WorkStations, Centerpoint Medical Center offers,favorable ... workstations are satisfying the needs of the,hospital,s nurses, physicians, ...
... October 13 The International Diabetes,Federation (IDF) announced today ... for action to secure care for the thousands of ... The meeting, Access to Essential Diabetes Medicines for ... October 25 in London, United,Kingdom. The International Diabetes Federation ...
Cached Biology Technology:Vista Partners Updates Coverage; Maintains $3.20 Target Price 2In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 2In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 3In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 4International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
(Date:7/21/2015)... July 21, 2015 Passwords have proven ... in the recent U.S. Office of Personnel Management ... the infosec conundrum, but developers and end-users are ... address this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced ... SDK for third party integration. ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3
... is pleased to announce that the 2014 HFSP Nakasone ... Weizmann Institute of Science for his pioneering work in ... the single most important foundation of the field of ... complexity of genetic circuits to systematic analysis and understanding. ...
... Medbox, Inc. (OTC Markets: MDBX) ( www.medboxinc.com ), a ... medical and retail industries, announced that their patented software and ... to meet the priorities spelled out by the US Department ... United States Attorneys titled, "Guidance Regarding Marijuana Enforcement." ...
... 320,000 viruses in mammals awaiting discovery. Collecting evidence of these ... provide information critical to early detection and mitigation of disease ... or $1.4 billion if limited to 85% of total viral ... major pandemic like SARS. Close to 70% of emerging ...
Cached Biology News:The 2014 HFSP Nakasone Award goes to Uri Alon 2Medbox's Marijuana Dispensing System Assists Operators in Complying with Federal Government's New Canna-Business Guidelines 2Medbox's Marijuana Dispensing System Assists Operators in Complying with Federal Government's New Canna-Business Guidelines 3First estimate of total viruses in mammals 2First estimate of total viruses in mammals 3First estimate of total viruses in mammals 4